What are the two specific reversal agents for dabigatran?
The two specific reversal agents for dabigatran are Idarucizumab and Andexanet Alfa. Idarucizumab is a humanized monoclonal antibody fragment developed as a specific reversal agent for dabigatran, while Andexanet Alfa is a specific reversal agent for direct and indirect factor Xa inhibitors.